| License: Publishing license for publications including print on demand (2MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-292823
- DOI to cite this document:
- 10.5283/epub.29282
Abstract (German)
Ziel dieser Arbeit war es, die proliferationshemmende Wirkung verschiedener GHRH-Antagonisten und des mTOR-Inhibitors Rapamycin sowie eine mögliche synergistische oder gar potenzierende Wirkung des kombinierten Einsatzes beider Wirkstoffe auf Hormonrezeptor-negative Mammakarzinomzelllinien zu untersuchen. Da für triple-negative Mammakarzinome – also Karzinome ohne Expression von Östrogen- und ...

Translation of the abstract (English)
The aim of this study was the investigation of the antiproliferative effect of several GHRH antagonists and the mTOR inhibitor Rapamycin, as well as a possible synergistic or even potentiating effect of the combined use of both substances upon hormone receptor-negative breast cancer cell lines. Because for triple negative breast cancer – i. e. carcinomas without expression of estrogen and ...
